Cytogen Inc Ordinary Shares 217330
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₩2,280.00
- Day Range
- ₩2,155.00–2,340.00
- 52-Week Range
- ₩2,100.00–11,200.00
- Bid/Ask
- ₩2,245.00 / ₩2,255.00
- Shares Outstanding
- 23.13M
- Market Cap
- ₩51.92B
- Volume/Avg
- 27,487 / 52,881
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.92
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Cytogen Inc is a Korea based company engaged in developing HD Microporous chip using microfluidics and nanotechnology and it captures viable CTCS (circulating tumor cells) from cancer patients blood. The firm operates in two business areas including Liquid Biopsy Applications and Liquid Biopsy Platforms. Its services and products include: cancer drug development and monitoring, companion diagnostics, clinical research, CLIA-certified services, preclinical xenograft models, and liquid biopsy equipment.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Growth
- Total Number of Employees
- 45
- Website
- http://www.cytogenlab.com
Valuation
Metric | 217330 |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.17 |
Price/Sales | 1.92 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | 217330 |
|---|---|
Quick Ratio | 6.30 |
Current Ratio | 7.21 |
Interest Coverage | −4.94 |
Quick Ratio
217330
Profitability
Metric | 217330 |
|---|---|
Return on Assets (Normalized) | −13.57% |
Return on Equity (Normalized) | −28.45% |
Return on Invested Capital (Normalized) | −12.76% |
Return on Assets
217330
Diagnostics & Research Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc TMO | LOCK|rsR$#zH< | LOCK|ymH | $255B | |||
| Danaher Corp DHR | LOCK|?wGLD!$ | LOCK|&J | $160B | |||
| IDEXX Laboratories Inc IDXX | LOCK|%H!bHt% | LOCK|?^ | $54B | |||
| Agilent Technologies Inc A | LOCK|tqcpx@d | LOCK|st^ | $49B | |||
| Waters Corp WAT | LOCK|YV!$@pN | LOCK|V#H | $45B | |||
| IQVIA Holdings Inc IQV | LOCK|Y@SvC? | LOCK|>%cW | $41B | |||
| Mettler-Toledo International Inc MTD | LOCK|%$$Ys<J | LOCK|VYYKs | $34B | |||
| Illumina Inc ILMN | LOCK|>>>Dy&j | LOCK|hzdkS | $30B | |||
| Labcorp Holdings Inc LH | LOCK|&?C%hGTC | LOCK|$bc# | $30B | |||
| Quest Diagnostics Inc DGX | LOCK|y&&DGf | LOCK|%?M<? | $29B |